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Abstract
Neutrophils play a key role in innate immunity, and the 
identification of new stimuli that stimulate neutrophil 
activity is a very important issue. In this study, we iden-
tified three novel peptides by screening a synthetic 
hexapeptide combinatorial library. The identified pep-
tides GMMWAI, MMHWAM, and MMHWFM caused an 
increase in intracellular Ca
2+ in a concentration-de-
pendent manner via phospholipase C activity in human 
neutrophils. The three peptides acted specifically on 
neutrophils and monocytes and not on other non-leu-
kocytic cells. As a physiological characteristic of the 
peptides, we observed that the three peptides induced 
chemotactic migration of neutrophils as well as stimu-
lated superoxide anion production. Studying receptor 
specificity,  we  observed  that  two  of  the  peptides 
(GMMWAI and MMHWFM) acted on formyl peptide re-
ceptor (FPR)1 while the other peptide (MMHWAM) act-
ed on FPR2. Since the three novel peptides were specif-
ic agonists for FPR1 or FPR2, they might be useful tools 
to study FPR1- or FPR2-mediated immune response 
and signaling.
Keywords: calcium; chemotaxis; neutrophils; pep-
tide library; peptides; receptors, formyl peptide 
Introduction
Neutrophils play an important role in the regulation 
of immune responses, especially in the innate 
immune response (Kumar and Sharma, 2010). 
Neutrophils are recruited to infected areas or sites 
of injury according to a chemoattractant gradient 
(Borregaard, 2010; Kumar and Sharma, 2010). 
Recruited neutrophils can be activated by extra-
cellular stimuli, resulting in the production of 
several reactive oxygen species (Dahlgren and 
Karlssson, 1999; Walther et al., 2000; Tiffany et al., 
2001). It is a critical aspect of resting neutrophils 
that they must be activated for host defense. The 
activation of neutrophils can be induced by various 
different stimuli, including pathogen-derived 
molecules and several chemoattractants (Walther 
et al., 2000; Tiffany et al., 2001; Sabroe et al., 
2003; Kobayashi, 2008). Among these, chemo-
attractants, including several chemokines that 
regulate the activities of neutrophils, have received 
much attention over the last decade. These 
chemoattractants bind to specific cell surface 
receptors, which are coupled to pertussis toxin 
(PTX)-sensitive G-protein(s), resulting in intracel-
lular Ca
2+ mobilization, cell migration, exocytosis, 
adhesion, and generation of bioactive lipids and/or 
reactive oxygen species (Walther et al., 2000; 
Tiffany et al., 2001; Kobayashi, 2008). Keeping in 
mind the important roles of chemoattractants in Novel neutrophil-activating peptides    131
Figure  1. Initial screening of PS- 
SPCLs for peptides stimulating in-
tracellular Ca
2+ increase in human 
neutrophils. Each panel shows the 
results obtained with the peptide 
pools with known amino acids at 
each of the six positions of the 
hexapeptide. The six positions were 
individually defined (O1, O2 etc.) by 
one of the 19 L-amino acids. The re-
maining five positions consist of 
mixtures (X) of the 19 L-amino acids 
(except for cysteine). Human neu-
trophils (1 ×10
6 cells/assay) were 
used for each assay. Fluorescence 
ratio (340/38) was monitored as de-
scribed under Methods. The results 
represent one of three independent 
experiments.
neutrophils, the identification of new chemoattrac-
tants and the characterization of their mechanisms 
of action are very much needed. 
    For the identification of new bioactive molecules, 
various different types of molecular diversities can 
be used. Positional scanning synthetic peptide 
combinatorial library (PS-SPCL), which is an easy 
and powerful tool for identifying peptide sequences 
in certain biological reactions, was developed by 
Houghten  et al. (Houghten et al., 1991). Many 
groups have used this method for various pur-
poses, including the identification of human im-
munodeficiency virus protease inhibitors, interleu-
kin-8-specific antagonists, inhibitor for nuclear factor 
of activated T cells, and ligands for opioid receptors 
(Owens et al., 1991; Hayashi et al., 1995; Dooley et 
al., 1998; Aramburu et al., 1999). Further, we already 
identified several bioactive hexapeptide that stimulates 
superoxide anion production or arachidonic acid 
release by screening hexapeptide combinatorial 
libraries (Bae et al., 2001, 2003). 
        Here, we adopted the PS-SPCL method to 
identify novel peptides that can stimulate a Ca
2+ 
increase in human neutrophils. We found that the 
peptides Gly-Met-Met-Trp-Ala-Ile-CONH2 (GMMWAI), 
Met-Met-His-Trp-Ala-Met-CONH2 (MMHWAM), and 
Met-Met-His-Trp-Phe-Met-CONH2 (MMHWFM) can 
stimulate human neutrophils, resulting in intra-
cellular Ca
2+ increase. We also investigated the 
functional roles of the peptides and the target 
receptors of these three peptides.
Results
Identification of peptides that stimulate Ca
2+ increase 
in human neutrophils 
A total of 114 peptide pools (around 47 million 
peptides) from hexapeptide PS-SPCLs were 
screened to identify peptides that stimulate a Ca
2+ 
increase in human neutrophils. As shown in Figure 
1, we observed that each amino acid that was fixed 
at each position induced different levels of Ca
2+ 
increase from the initial screening. The most active 
peptides at each position were as follows: Met (M) 
or Gly (G) in the 1st position, Met (M) in 2nd, His 
(H) or Met (M) in 3rd, Trp (W) in 4th, Ala (A) in 5th, 
and Met (M) or Ile (I) in 6th. 
Peptides-induced Ca
2+ increase is mediated via 
G-proteins and PLC 
Based on the results of the initial screening of the 
peptide libraries, we synthesized three represen-
tative hexapeptides (GMMWAI, MMHWAM, and 
MMHWFM) and confirmed that stimulation of 
neutrophils with various concentrations of these 
three peptides induced a Ca
2+ increase in a con-
centration-dependent manner with maximal activity 
of 0.5-5 μM (Figures 2A-2C). 
    Intracellular  Ca
2+ increase can be induced by 
several different pathways. Firstly, the activation of 
some types of Ca
2+ channels elicits intracellular 
Ca
2+ increase in leukoyctic cells (Berridge, 1993; 
Burnashev, 1998; Zhu et al., 2010). Since we 
observed that the three novel peptides increased 
intracellular Ca
2+ levels in human neutrophils, we 
examined the involvement of the cell surface Ca
2+ 
channel. For this, we used several different Ca
2+ 
channel-selective inhibitors. As shown in Figure 
2D, MMHWAM-induced intracellular Ca
2+ increas-
es were not affected by preincubating human 
neutrophils with 1 μM nifedifine (voltage-sensitive L 
type Ca
2+ channel inhibitor), 10 μM diltiazem 
(voltage-sensitive L type Ca
2+ channel inhibitor), 
and 10 μM SK&F. These results indicate that 132    Exp. Mol. Med. Vol. 44(2), 130-137, 2012
Figure 2. Effects of peptides on Ca
2+ increase in human neutrophils. Fura-2-loaded human neutrophils were stimulated with various concentrations of 
GMMWAI, MMHWAM, and MMHWFM. The change in 340 nm/380 nm was monitored. The peak level of the increase in Ca
2+ was monitored. Data are 
presented as means ±S.E. of four independent experiments (A-C). Fura-2-loaded human neutrophils were stimulated with 5 μM MMHWAM in the ab-
sence or presence of SK&F (10 μM), diltiazem (1 μM), nifidifin (1 μM), U-73122 (5 μM), U-73343 (5 μM), and 2A-PB (5 μM). The change in 340 nm/380 
nm was monitored. The results are representative of three independent experiments (D, E). Human neutrophils were preincubated with or without 1 μg/ml 
of PTX for 4 h, after which fura-2 was loaded into the cells. Fura-2-loaded cells were stimulated with 5 μM MMHWAM. The peak level of the increase in 
Ca
2+ was monitored. Data are presented as means ±S.E. of three independent experiments (F). *, P ＜ 0.05, compared with the value obtained from 
the vehicle control; 
#, P ＜ 0.05, significantly different from the -PTX control.
MMHWAM increased Ca
2+ concentration indepen-
dent of the Ca
2+ channel-dependent pathway in 
human neutrophils. 
    Another pathway for intracellular Ca
2+ increase 
is mediated by the activation of PLC (Noh et al., 
1995; Rhee, 2001). To determine the role of PLC in 
the MMHWAM-induced Ca
2+ increase, we pre-
treated cells with a specific PLC inhibitor, U-73122, 
or with its inactive analogue, U-73343. As shown in 
Figure 2E, U-73122 but not U-73343 completely 
inhibited the MMHWAM-induced Ca
2+ increase. 
2-aminoethoxydiphenyl borate (2-APB), which is 
used to block IP3 receptor in cells (Maruyama et 
al., 1997), also completely inhibited the MMHWAM- 
induced Ca
2+ increase in human neutrophils (Figure 
2E). These results indicate that MMHWAM stimulated 
Ca
2+ increase via PLC activation in human neutrophils. 
MMHWAM resulted in intracellular Ca
2+ elevation 
not only in the presence of extracellular Ca
2+ but 
also in the absence of extracellular Ca
2+ (data not 
shown), supporting that the peptide induced Ca
2+ 
increase  via the activation of PLC in human 
neutrophils. 
    We also examined the effect of PTX, a specific 
inhibitor of Gi/o type G proteins, on the peptides- 
induced Ca
2+ increase. When human neutrophils 
were preincubated with 1 μg/ml of PTX prior to 
stimulation with MMHWAM, the peptides-induced 
Ca
2+ increase was almost completely inhibited 
(Figure 2F). These results indicate that MMHWAM 
stimulated Ca
2+ increase via PTX-sensitive G pro-
teins. We also observed that the other two 
peptides (GMMWAI and MMHWFM) stimulated 
Ca
2+ increase via Gi protein and PLC but not the 
Ca
2+ channel (data not shown). 
Leukocyte-specific effects of the novel peptides
The fact that GMMWAI, MMHWAM, and 
MMHWFM stimulated human neutrophils led us to 
examine the effects of the peptides on other 
leukocytes such as monocytes. Stimulation of 
monocytes with the three peptides resulted in Ca
2+ 
increase (Figure 3). The three peptides also 
enhanced Ca
2+ levels in monocytes with a similar 
concentration dependency as observed for the 
Ca
2+ increase (Figure 3 and data not shown). Next, 
we examined the effects of GMMWAI, MMHWAM, 
and MMHWFM on intracellular Ca
2+ release in 
several non-leukocytic cell lines. NIH3T3 (NIH 
Swiss mouse embryo fibroblast), 3Y1 (Rat embryo-
nic fibroblast), 3T3L1 (preadipocyte), and PC12 Novel neutrophil-activating peptides    133
Figure 3. Cell specificity of the peptides. Prepared human primary monocytes, neutrophils, NIH3T3, 3Y1, 3T3L1, and PC12 cells were loaded with fura-2 
and stimulated with three peptides at a concentration of 10 μM. The peak level of the Ca
2+ increase was recorded. Data are presented are means ±S.E. 
from at least three independent experiments.
Figure 4. Chemotactic effects of the peptides. Assays were performed using a modified Boyden chamber assay. Isolated human neutrophils (1 ×10
6 
cells/ml of serum-free RPMI 1640) were added to the upper wells of a 96-well chemotaxis chamber, and migration across the polycarbonate membrane 
with 3-μm pore size was assessed after 1.5 h of incubation at 37
oC (A-C). Human neutrophils were incubated with or without 1 μg/ml of PTX for 4 h. 
Then, the cells were used for chemotaxis assay using 5 μM GMMWAI, MMHWAM, or MMHWFM (D-F). The numbers of migrated cells were determined 
by counting them in high power field (400X). The data are presented as mean ±S.E. of three independent experiments, each performed in duplicate. *P
＜ 0.05, compared with the value obtained from the vehicle control; 
#P ＜ 0.05, significantly different from the -PTX control.
(rat adrenal pheochromocytoma) cells showed no 
response to the three peptides in terms of Ca
2+ 
increase (Figure 3). From these results, we 
suggest that the effects of the three peptides were 
specific to human leukocytes.
Chemotactic effects of the novel peptides on human 
neutrophils
We demonstrated that the novel peptides sti-
mulated Ca
2+ increase in human neutrophils in a 
PTX-sensitive manner. Since peptides-induced 
and chemoattractant-induced neutrophil activation 
are similar to each other, we investigated whether 
or not the peptides exhibit chemotactic activity on 
human neutrophils. GMMWAI, MMHWAM, and 
MMHWFM induced migration of human neutrophils 
within a 0.1-5 μM concentration, showing concen-
tration response curves (Figures 4A-4C). This implies 
that the three novel peptides induced chemotaxis 
in human neutrophils.
    Various  extracellular  stimuli,  including  many 
chemoattractants, activate neutrophils via PTX- 
sensitive G-protein(s) (Badolato et al., 1995; Bae 
et al., 1999). Here, we also examined the involve-
ment of PTX-sensitive G-protein(s) on peptide-in-134    Exp. Mol. Med. Vol. 44(2), 130-137, 2012
Figure 5. Effects of peptides on superoxide anion production in human neutrophils. Human neutrophils were stimulated with various concentrations of 
GMMWAI, MMHWAM, or MMHWFM, and the amount of generated superoxide was measured using cytochrome c reduction assay. The data are pre-
sented as mean ±S.E. of three independent experiments, each performed in duplicate. *P ＜ 0.01 versus vehicle treatment.
Figure 6. Role of FPR1 or FPR2 in 
novel peptide-induced Ca
2+ increase. 
Isolated human neutrophils were in-
cubated in the presence or absence 
of 10 μM CsH or WRW4 prior to 
Ca
2+ measurement using 5 μM 
GMMWAI (A), 5 μM MMHWAM (B), 
or 5 μM MMHWFM (C). Vector- (D), 
FPR1- (E), or FPR2- (F) expressing 
RBL-2H3 cells (1 ×10
6 cells/ml of 
serum-free RPMI 1640 medium) were 
stimulated with 5 μM GMMWAI, 5 
μM MMHWAM, or 5 μM MMHWFM. 
The results represent one of two in-
dependent experiments.
duced neutrophil chemotaxis. Preincubation of 
human neutrophils with PTX (1 μg/ml) for 4 h 
caused complete inhibition of peptides-induced 
neutrophil chemotaxis (Figure 4D-F). The results 
indicate that GMMWAI, MMHWAM, and MMHWFM 
stimulated human neutrophil chemotaxis via PTX- 
sensitive G-protein(s). 
MMHWAM and MMHWFM but not GMMWAI stimulate 
superoxide anion production from human 
neutrophils
In this study, we found that the three novel pep-
tides stimulated not only intracellular Ca
2+ increase 
but also chemotactic migration via PTX-sensitive 
G-protein(s). Neutrophils perform an important role 
in the innate immune response by producing a 
large amount of superoxide anion after stimulation 
with extracellular stimuli (Dahlgren and Karlsson, 
1999). Superoxide anion is a well-known method of 
killing invading pathogens employed by human 
neutrophils (Rossi, 1986; Segal and Abo, 1993; 
Dahlgren and Karlsson, 1999). Here, we also 
tested the effects of the three novel peptides on 
the generation of superoxide anion from human 
neutrophils. Stimulation of human neutrophils with 
various concentrations of GMMWAI failed to 
induce superoxide anion production (Figure 5A). 
However, the other two novel peptides (MMHWAM 
and MMHWFM) strongly increased superoxide 
anion production from human neutrophils (Figures 
5B and 5C). 
Novel peptides stimulate formyl peptide receptor 
(FPR)1 or FPR2
The three peptides showed similar effects on 
human neutrophils, in terms of Ca
2+ increase and Novel neutrophil-activating peptides    135
chemotactic migration via PTX-sensitive G-pro-
tein(s) (Figure 2F and data not shown). Formyl 
peptide receptors are representative chemoattrac-
tant receptors in human neutrophils (Ye et al., 
2009). Here, we attempted to determine whether or 
not the three peptides acted through FPR1 and 
related receptors. For this purpose, we used FPR1 
antagonist (CsH) (de Paulis et al., 1996) and FPR2 
antagonist (WRW
4) (Bae et al., 2004). As shown in 
Figures 6A and 6C, GMMWAI- and MMHWFM-in-
duced Ca
2+ increases were totally inhibited by CsH 
but not by WRW
4. However, MMHWAM-induced 
Ca
2+ increase was completely blocked by WRW
4 
but not by CsH (Figure 6B). These results suggest 
that GMMWAI and MMHWFM stimulated Ca
2+ 
increases via FPR1 but not FPR2. On the other 
hand, MMHWAM stimulated a Ca
2+ increase via 
FPR2 but not FPR1. We also used vector, FPR1-, 
or FPR2-expressing RBL-2H3 cells as previously 
reported (Lee et al., 2008). As shown in Figure 6E, 
stimulation of FPR1-expressing RBL-2H3 cells with 
the two novel peptides (GMMWAI and MMHWFM) 
elicited a dramatic increase in intracellular Ca
2+. 
However, the two peptides did not induce an 
intracellular Ca
2+ increase in vector- or FPR2- 
expressing RBL-2H3 cells (Figures 6D and 6F). 
These results strongly indicate that the two pep-
tides (GMMWAI and MMHWFM) stimulated FPR1 
but not FPR2, resulting in an increase in Ca
2+. For 
MMHWAM, Ca
2+ increase was observed in FPR2- 
expressing RBL-2H3 cells but not in FPR1-ex-
pressing RBL-2H3 cells (Figure 6E). The result 
indicates that MMHWAM acted through FPR2, 
increasing intracellular Ca
2+. 
Discussion
Since neutrophils perform important roles in early 
defense against invading pathogens and other 
harmful agents (Borregaard, 2010; Kumar and 
Sharma, 2010), the identification of agonists that 
enhance neutrophil function is of paramount 
importance. Here, we screened hexapeptide com-
binatorial libraries containing more than 47 million 
different peptide sequences, and we identified 
three novel hexapeptides (GMMWAI, MMHWAM, 
and MMHWFM) that stimulate intracellular Ca
2+ 
increase in human neutrophils. GMMWAI and 
MMHWFM were shown to have selectivity on 
FPR1 but not on FPR2. In the case of MMHWAM, 
the peptide showed selectivity on FPR2 but not on 
FPR1. 
    Specific  ligands  are  recognized  by  specific 
receptors, and this specificity results from a com-
bination of subtle conformational and amino acid 
sequence differences. Previously some synthetic 
hexapeptides, WKYMVm, MFYLPM, HFYLPM, and 
HFYLPm, which act at two fMLF receptor subtypes 
have been described (Seo et al., 1997; Bae et al., 
2001). In our previous reports, we demonstrated 
that the Y in the 3
rd position of the hexapeptide and 
the M in the 6
th position are important for stimula-
tion of FPR family proteins (Bae et al., 2001). Here, 
we found that other peptides having different 
amino acids at the 3
rd and 6
th positions, such as 
H/M (for 3
rd position) and I (for 6
th position), showed 
stimulating activity on FPR family proteins. These 
results suggest that FPR1 has a broad spectrum of 
ligand recognition capacity. On the receptor speci-
ficity of MMHWAM and MMHWFM, we demon-
strated that MMHWFM and MMHWAM acted on 
FPR1 and FPR2, respectively (Figures 6E and 6F). 
The result indicates that the 5
th amino acid is 
important for the recognition of the peptides by 
FPR1 or FPR2. 
    Since  GMMWAI,  MMHWAM,  and  MMHWFM 
were identified by screening artificially synthesized 
peptides, we looked for sequence similarities 
between the novel peptides and known proteins by 
searching databases (SWISS-PROT and TrEMBL), 
and found that several bacterial proteins such as 
aminoacyltransferase femB contained the MMHWFM 
sequence. At this time, we cannot attach any 
significance to this sequence homology between 
our novel peptides and bacterial proteins. However, 
since FPRs recognize certain patterns derived 
from pathogens, the information that our peptides 
carry certain bacterial sequences may provide us 
useful insights into understanding the pattern 
involved in the recognition of pathogens. 
    Even  though  various  chemokines  and  chemo-
attractants have been identified, only a few short 
peptides acting on human leukocytes have been 
known until now. The previously reported peptides 
WKYMVm (Seo et al., 1997) and fMLF (Spilberg et 
al., 1981) have been useful tools for studying 
neutrophil activation. Here, we demonstrated that 
the novel peptides GMMWAI, MMHWAM, and 
MMHWFM stimulate human neutrophils by acting 
on FPR1 or FPR2 (Figure 6). Therefore, these 
three peptides can also be used as agonists to 
study neutrophil activation and signaling.
Methods
Materials 
Peripheral blood mononuclear cell (PBMC) separation me-
dium (Histopaque-1077) and cytochrome c were pur-
chased from Sigma (St. Louis, MO). Fura-2 pentaacetoxy-
methylester (fura-2/AM) was purchased from Molecular 136    Exp. Mol. Med. Vol. 44(2), 130-137, 2012
Probes (Eugene, OR). PTX was purchased from Calbio-
chem (San Diego, CA). 
Isolation of leukocytes 
The Institutional Review Board (IRB) of Ajou University 
Hospital specifically approved this study (approval ID: 
AJIRB-MED-SMP-10-074). We obtained written informed 
consent from all participants involved in this study. 
Peripheral blood leukocytes were isolated from healthy 
donors. Human neutrophils were isolated according to the 
standard procedures of dextran sedimentation, hypotonic 
lysis of erythrocytes, and a lymphocyte separation medium 
gradient as described previously (Bae et al., 2001). 
PBMCs were separated on a Histopaque-1077 gradient. 
After two washings with HBSS without Ca
2+ and Mg
2+, the 
PBMCs were suspended in 10% FBS containing RPMI 
1640 and incubated for 60 min at 37
oC to allow attachment 
of monocytes to the culture dish. The cells were washed 
five times with warm RPMI medium to washout lympho-
cytes, after which the attached monocytes were collected 
as described previously (Bae et al., 2001). The isolated hu-
man leukocytes were then used promptly. 
Cell culture 
NIH3T3 (NIH Swiss mouse embryo fibroblasts), 3Y1 (Rat 
embryonic fibroblasts), 3T3L1 (preadipocytes), and PC12 
(rat adrenal pheochromocytoma) cells were obtained from 
the American Type Culture Collection (Rockville, MD) and 
maintained as recommended. The cells were maintained at 
about 1 ×10
6 cells/ml under standard incubator conditions 
(humidified atmosphere, 95% air, 5% CO2, 37
oC). 
Initial screening of PS-SPCLs and measurement of 
intracellular Ca
2+ increase 
The hexapeptide libraries were obtained from the Peptide 
Library Support Facility of Pohang University of Science 
and Technology as described previously (Bae et al., 2001). 
Finally, 114 peptide pools (Cys was excluded in the con-
struction of the libraries) were individually dissolved in wa-
ter at a final concentration of 27 nM per peptide sequence 
in each pool. For initial screening of the PS-SPCLs, we 
measured the level of [Ca
2+]i by using Grynkiewicz’s meth-
od with fura-2/AM (Grynkiewicz et al., 1985). Briefly, pre-
pared cells were incubated with 3 μM fura-2/AM at 37
oC for 
50 min in fresh serum-free RPMI 1640 medium under con-
tinuous stirring. Then, 2 ×10
6 cells were aliquoted for 
each assay in Ca
2+-free Locke's solution (154 mM NaCl, 
5.6 mM KCl, 1.2 mM MgCl2, 5 mM HEPES, pH 7.3, 10 mM 
glucose, and 0.2 mM EGTA) and incubated with the in-
dicated concentrations of peptide pools (final 50 pM per 
peptide sequence for the initial screening). Fluorescence 
changes at the dual excitation wavelengths of 340 nm and 
380 nm and the emission wavelength of 500 nm were 
measured, and the calibrated fluorescence ratio was trans-
lated into [Ca
2+]i. 
Chemotaxis assay 
Chemotaxis assays were performed using multiwell cham-
bers (Neuroprobe Inc., Gaithersburg, MD) (Bae et al., 
2001). Briefly, prepared human neutrophils were sus-
pended in RPMI 1640 at a concentration of 1 ×10
6 cells/ml, 
and 25 μl of the suspension was placed into the upper well 
of a chamber separated by a 3 μm polyhydrocarbon filter 
from the lower well containing peptides. After incubation for 
90 minutes at 37
oC, non-migrated cells were removed by 
scarping, and cells that migrated across the filter were de-
hydrated, fixed, and stained with hematoxylin (Sigma, St. 
Louis, MO). Stained cells in five randomly chosen high 
power fields (400X) in the well were then counted (Bae et 
al., 2001). 
Measurement of superoxide anion production
Superoxide anion generation was determined by measur-
ing cytochrome c reduction using a microtiter 96-well plate 
ELISA reader (Bio-Tek instruments, EL312e, Winooski, 
VT), as previously described (Bae et al., 2001). Human 
neutrophils (2 ×10
6 cells in RPMI 1640 medium) were pre-
incubated with 50 μM cytochrome c at 37
oC for 5 min and 
subsequently incubated with each peptide. Superoxide 
generation was determined by measuring light absorption 
changes at 550 nm over 5 min at 1 min intervals.
Statistical analysis
The results are expressed as mean ±S. E. of data ob-
tained from the indicated number of experiments per-
formed. Statistical significance was determined using the 
Student t test.
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